Status:
COMPLETED
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
Lead Sponsor:
National Healthcare Group, Singapore
Conditions:
Peritoneal Dialysis Catheter Exit Site Infection
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
Exit site infection (ESI) is one of the major predisposing factors to peritoneal dialysis (PD) related peritonitis. Chlorhexidine Gluconate (CHG) has been widely used for cutaneous disinfection for ha...
Detailed Description
Peritoneal Dialysis (PD) is one of the common therapies for patients with End Stage Renal Failure (ESRF). As the global burden of chronic kidney disease continues to increase, so does the need for a c...
Eligibility Criteria
Inclusion
- All incident PD patients
Exclusion
- Patients allergic to chlorhexidine and Tegaderm dressing
Key Trial Info
Start Date :
September 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06022835
Start Date
September 27 2019
End Date
July 31 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allen Liu
Singapore, Singapore